MDGL 250516 370.00P(MDGL250516P370000) Stock Price Today

US OptionsDetailed Quotes

MDGL250516P370000

Watchlist

48.16
0.000.00%

15min DelayTrading Mar 21 12:33 ET

0.00High0.00Low

Intraday

5D
Daily

News

Earnings Preview: MDGL to Report Financial Results Pre-market on May 01
Moomoo NewsApr 25 21:00 ET
12 Health Care Stocks Moving In Friday's After-Market Session
BenzingaApr 25 17:06 ET
Evercore Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $392
Moomoo NewsApr 25 04:32 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Pfizer (PFE) and Madrigal Pharmaceuticals (MDGL)
TipRanksApr 25 04:10 ET · Ratings
JMP Securities Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $443
Moomoo NewsApr 25 01:33 ET · Ratings
Express News | JMP Securities Reiterates Market Outperform on Madrigal Pharmaceuticals, Maintains $443 Price Target
BenzingaApr 24 10:23 ET

Comments

Teddy123

Feb 26 19:41

Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH

$Madrigal Pharmaceuticals (MDGL.US)$
Can Madrigal's Rezdiffra Breakthrough in Cirrhosis Patients Transform Liver Disease Treatment?

Stock_Drift

Nov 1, 2024 23:33

Unusual Volume Ticks. 11:32am

$Madrigal Pharmaceuticals (MDGL.US)$ $Nuburu (BURU.US)$ $Pro-Dex (PDEX.US)$ $ASP Isotopes (ASPI.US)$ $GRI Bio (GRI.US)$ $Vast Renewables (VSTE.US)$ $MicroCloud Hologram (HOLO.US)$ $Theriva Biologics (TOVX.US)$ $Pluribus Technologies Corp (PLRB.CA)$ $Ensysce Biosciences (ENSC.US)$ $Athira (ATHA.US)$ $Globalstar (GSAT.US)$ $ChromaDex (CDXC.US)$
📊⚡️📊

Jerry Kronenberg

Jun 12, 2024 03:52

Columns Madrigal Pharmaceuticals Rallies 15% on Wolfe Research 'Outperform' Rating

$Madrigal Pharmaceuticals (MDGL.US)$ rose some 15% Tuesday after Wolfe Research reportedly initiated coverage of the pharma firm with a "Outperform" rating.
MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports.
The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...

Meltyy

May 16, 2024 14:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

Meltyy

May 16, 2024 14:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...